Literature DB >> 10971746

Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis.

C M Gomes1, H Goto, V L Ribeiro Da Matta, M D Laurenti, M Gidlund, C E Corbett.   

Abstract

While the control or progression of leishmaniasis depends on host immune responses, the initial inflammatory process represents a key event. This process involves the participation of several cytokines and growth factors induced during inflammation as well as factors already present at the site of infection such as insulin-like growth factor (IGF)-I. We have previously demonstrated a potential role for IGF-I in experimental cutaneous leishmaniasis based on the significant increase in lesion size seen in mice injected with Leishmania promastigotes preactivated with IGF-I. In the present study we show that preactivation of Leishmania (Leishmania) amazonensis promastigotes with IGF-I induces an increase in the actual number of parasites at the lesion site from seven days postinfection, in addition to a more intense inflammatory infiltrate. There was a higher numerical density of polymorphonuclear neutrophils from 3 to 24 h, and of mononuclear cells from 48 h of infection onward. A higher density of polymorphonuclear neutrophils and mononuclear cells harboring parasites was also observed. The most important observation, however, was that more parasites per cell were present, revealing that IGF-I appears to favour parasite growth within the macrophages. These results strongly suggest an important role for IGF-I in the development of cutaneous leishmaniasis, where it influences both the inflammatory process and parasite growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971746      PMCID: PMC2517735          DOI: 10.1046/j.1365-2613.2000.00157.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  24 in total

1.  Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation.

Authors:  I Vouldoukis; P A Bécherel; V Riveros-Moreno; M Arock; O da Silva; P Debré; D Mazier; M D Mossalayi
Journal:  Eur J Immunol       Date:  1997-04       Impact factor: 5.532

2.  Insulin-like growth factor-1 is a growth promoting factor for Leishmania promastigotes.

Authors:  C M Gomes; H Goto; C E Corbett; M Gidlund
Journal:  Acta Trop       Date:  1997-04-15       Impact factor: 3.112

3.  Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937.

Authors:  I Nagaoka; B C Trapnell; R G Crystal
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

4.  Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone.

Authors:  J B Baxter; J E Blalock; D A Weigent
Journal:  Endocrinology       Date:  1991-10       Impact factor: 4.736

5.  Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells.

Authors:  S L Abboud; C R Bethel; D C Aron
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

6.  Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages.

Authors:  E L Racoosin; S M Beverley
Journal:  Exp Parasitol       Date:  1997-03       Impact factor: 2.011

Review 7.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

8.  Leishmanicidal mechanisms of human polymorphonuclear phagocytes.

Authors:  K P Chang
Journal:  Am J Trop Med Hyg       Date:  1981-03       Impact factor: 2.345

9.  Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.

Authors:  W Y Weiser; A Van Niel; S C Clark; J R David; H G Remold
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Macrophages and neutrophils cooperate in immune responses to Leishmania infection.

Authors:  Alessandra A Filardy; Dayana R Pires; George A DosReis
Journal:  Cell Mol Life Sci       Date:  2011-03-03       Impact factor: 9.261

2.  Insulin-like growth factor-I induces arginase activity in Leishmania amazonensis amastigote-infected macrophages through a cytokine-independent mechanism.

Authors:  Celia Maria Vieira Vendrame; Marcia Dias Teixeira Carvalho; Andre Gustavo Tempone; Hiro Goto
Journal:  Mediators Inflamm       Date:  2014-09-09       Impact factor: 4.711

3.  Antileishmanial activity of medicinal plants used in endemic areas in northeastern Brazil.

Authors:  Aline Cavalcanti De Queiroz; Thays de Lima Matos Freire Dias; Carolina Barbosa Brito Da Matta; Luiz Henrique Agra Cavalcante Silva; João Xavier de Araújo-Júnior; Givanildo Bernardino de Araújo; Flávia de Barros Prado Moura; Magna Suzana Alexandre-Moreira
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-13       Impact factor: 2.629

4.  Insulin-Like Growth Factor-I as an Effector Element of the Cytokine IL-4 in the Development of a Leishmania major Infection.

Authors:  Luiza C Reis; Eduardo Milton Ramos-Sanchez; Fabricio Petitto-Assis; Audun H Nerland; Maria Hernandez-Valladares; Frode Selheim; Lucile Maria Floeter-Winter; Hiro Goto
Journal:  Mediators Inflamm       Date:  2018-07-29       Impact factor: 4.711

Review 5.  Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.

Authors:  Luiza C Reis; Eduardo Milton Ramos-Sanchez; Fernanda N Araujo; Ariane F Leal; Christiane Y Ozaki; Orlando R Sevillano; Bernardina A Uscata; Hiro Goto
Journal:  J Immunol Res       Date:  2021-05-04       Impact factor: 4.818

6.  Cell-to-cell transfer of Leishmania amazonensis amastigotes is mediated by immunomodulatory LAMP-rich parasitophorous extrusions.

Authors:  Fernando Real; Pilar Tavares Veras Florentino; Luiza Campos Reis; Eduardo M Ramos-Sanchez; Patricia Sampaio Tavares Veras; Hiro Goto; Renato Arruda Mortara
Journal:  Cell Microbiol       Date:  2014-06-13       Impact factor: 3.715

7.  The interactions and essential effects of intrinsic insulin-like growth factor-I on Leishmania (Leishmania) major growth within macrophages.

Authors:  L C Reis; E M Ramos-Sanchez; H Goto
Journal:  Parasite Immunol       Date:  2013-07       Impact factor: 2.280

8.  Comparative analysis of resistant and susceptible macrophage gene expression response to Leishmania major parasite.

Authors:  Imen Rabhi; Sameh Rabhi; Rym Ben-Othman; Mohamed Radhouane Aniba; Bernadette Trentin; David Piquemal; Béatrice Regnault; Lamia Guizani-Tabbane
Journal:  BMC Genomics       Date:  2013-10-22       Impact factor: 3.969

9.  Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis.

Authors:  Luana Dias de Souza; Célia Maria Vieira Vendrame; Amélia Ribeiro de Jesus; Márcia Dias Teixeira Carvalho; Andréa Santos Magalhães; Albert Schriefer; Luiz Henrique Guimarães; Edgar Marcelino de Carvalho; Hiro Goto
Journal:  Parasit Vectors       Date:  2016-06-11       Impact factor: 3.876

10.  Mycobacterium leprae-induced Insulin-like Growth Factor I attenuates antimicrobial mechanisms, promoting bacterial survival in macrophages.

Authors:  L R Batista-Silva; Luciana Silva Rodrigues; Aislan de Carvalho Vivarini; Fabrício da Mota Ramalho Costa; Katherine Antunes de Mattos; Maria Renata Sales Nogueira Costa; Patricia Sammarco Rosa; T G Toledo-Pinto; André Alves Dias; Danielle Fonseca Moura; Euzenir Nunes Sarno; Ulisses Gazos Lopes; Maria Cristina Vidal Pessolani
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.